BRIEF-Transition Therapeutics reports Q3 loss per share $0.11

Wed May 11, 2016 4:18pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

May 11 (Reuters) - Transition Therapeutics Inc

* Q3 loss per share $0.11

* Existing cash resources should enable co to execute business plan and meet projected cash requirements beyond next 12 months Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)